GinoKInMDMPH

Oncology • Los Angeles, CA

Melanoma

Assistant Professor of Clinical Medicine and Dermatology, Division of Medical Oncology

Join to view full profile

Dr. In is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Connect with other colleagues in the same hospital or clinic
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

See Dr. In's full profile

Already have an account?

Office
USC Norris Comprehensive Cancer Center
1441 Eastlake Ave NOR 3444
Los Angeles, CA 90033
Phone+1 323-865-3000

Fax+1 323-865-0061
Is this information wrong?

Education & Training

University of Southern California/LAC+USC Medical CenterFellowship, Medical Oncology, 2013 - 2016
SUNY Health Science Center at BrooklynResidency, Internal Medicine, 2011 - 2013
SUNY Health Science Center at BrooklynInternship, Internal Medicine, 2010 - 2011
Ross University School of MedicineClass of 2010
Emory University Rollins School of Public HealthMPH, Environmental and Occupational Health, 2004 - 2006
Emory UniversityBS, Biology, 1998 - 2002

Certifications & Licensure

CA State Medical License 2013 - 2024
American Board of Internal Medicine Hematology
American Board of Internal Medicine Medical Oncology

Clinical Trials

Testing the Addition of Navitoclax to the Combination of Dabrafenib and Trametinib in People Who Have BRAF Mutant Melanoma Start of enrollment: 2014 Mar 24
Active, not recruiting
Phase 1, Phase 2
SARC028: A Phase II Study of the Anti-PD1 Antibody Pembrolizumab (MK-3475) in Patients With Advanced Sarcomas Start of enrollment: 2015 Mar 01
Completed
Phase 2
Pembrolizumab in Treating Patients With Desmoplastic Melanoma That Can or Cannot Be Removed by Surgery Start of enrollment: 2017 Feb 06
Active, not recruiting
Phase 2
Nivolumab and Ipilimumab in Treating Patients With Rare Tumors Start of enrollment: 2017 Jan 30
Active, not recruiting
Phase 2
Talimogene Laherparepvec and Pembrolizumab in Treating Patients With Stage III-IV Melanoma Start of enrollment: 2018 Jun 05
Active, not recruiting
Phase 2
Talimogene Laherparepvec and Nivolumab in Treating Patients With Refractory Lymphomas or Advanced or Refractory Non-melanoma Skin Cancers Start of enrollment: 2017 Sep 27
Active, not recruiting
Phase 2
A Phase 1/2 Safety Study of Intratumorally Dosed INT230-6 Start of enrollment: 2017 Feb 09
Completed
Phase 1, Phase 2
PROCLAIM-CX-2009: A Trial to Find Safe and Active Doses of an Investigational Drug CX-2009 for Patients With Selected Solid Tumors Start of enrollment: 2017 Jun 01
Terminated
Phase 1, Phase 2
A Study of Cobimetinib Plus Atezolizumab Versus Pembrolizumab in Participants With Previously Untreated Advanced BRAFv600 Wild-Type Melanoma Start of enrollment: 2017 Dec 11
Terminated
Phase 3
A Study of Tilsotolimod in Combo With Ipilimumab vs Ipilimumab Alone in Subjects With Anti-PD-1 Refractory Melanoma Start of enrollment: 2018 May 30
Terminated
Phase 3
A Study to Compare the Administration of Pembrolizumab After Surgery Versus Administration Both Before and After Surgery for High-Risk Melanoma Start of enrollment: 2019 Feb 15
Active, not recruiting
Phase 2
Testing Pembrolizumab Versus Observation in Patients With Merkel Cell Carcinoma After Surgery, STAMP Trial Start of enrollment: 2018 Nov 15
Suspended
Phase 3
Avelumab With or Without Cetuximab in Treating Patients With Advanced Skin Squamous Cell Cancer Start of enrollment: 2019 May 17
Active, not recruiting
Phase 2
A PD-1 Checkpoint Inhibitor (Cemiplimab) for High-Risk Localized, Locally Recurrent, or Regionally Advanced Skin Cancer Start of enrollment: 2020 Jun 17
Recruiting
Phase 2
Short-term Fasting Prior to PD-1/PD-L1 Inhibitor Therapy for of Advanced or Metastatic Skin Malignancy Start of enrollment: 2020 Aug 12
Recruiting
Phase 1
Join now to see all

Publications & Presentations

PubMed

1 citations
Innate and adaptive immune cell interaction drives inflammasome activation and hepatocyte apoptosis in murine liver injury from immune checkpoint inhibitors.
Layla Shojaie, Jacob M Bogdanov, Helia Alavifard, Mahmoud G Mohamed, Aria Baktash, Myra Ali, Simeon Mahov, Sue Murray, Gary C Kanel, Zhang-Xu Liu, Fumito Ito, Gino K I...> ;Cell Death & Disease. 2024 Feb 14
1 citations
Multi-omic profiling reveals discrepant immunogenic properties and a unique tumor microenvironment among melanoma brain metastases.
Gino K In, Jennifer R Ribeiro, Jun Yin, Joanne Xiu, Matias A Bustos, Fumito Ito, Frances Chow, Gabriel Zada, Lindsay Hwang, April K S Salama, Soo J Park, Justin C Mose...> ;NPJ Precision Oncology. 2023 Nov 14
Cutaneous adverse effects induced by tebentafusp in patients with metastatic uveal melanoma: a case series and treatment insights.
Ivan Rodriguez, Thomas Norman, Jana Guenther, Kimberly Smart, Andrew Kwong, Jesse Berry, Gino K In, Scott Worswick> ;Clinical and Experimental Dermatology. 2024 Mar 21
Intraocular Spread of Ocular Surface Squamous Neoplasia Presenting as a Postoperative Anterior Chamber Opacity after Excisional Biopsy.
Sarah Pike, Stephanie B Engelhard, Maria E Sibug Saber, Anna J Matthew, Gino K In, Jesse L Berry> ;Case Reports in Ophthalmology. 2023 May 12
117 citations
Neoadjuvant-Adjuvant or Adjuvant-Only Pembrolizumab in Advanced Melanoma.
Sapna P Patel, Megan Othus, Yuanbin Chen, G Paul Wright Jr, Kathleen J Yost, John R Hyngstrom, Siwen Hu-Lieskovan, Christopher D Lao, Leslie A Fecher, Thach-Giao Truon...> ;The New England Journal of Medicine. 2023 Mar 2
2 citations
A retrospective analysis of rates of dermatology follow-up and new skin cancer diagnosis among solid organ transplant recipients during the COVID-19 pandemic.
Ritika Saranath, Braulio Fernandez, Jacob Gomez, Melanie Miller, Danielle Novack, Neha Parvathala, Ema Shah, Shannon Wong-Michalak, Jack Rodman, Michael W Fong, Sivagi...> ;JAAD International. 2023 Mar 1
Safety and efficacy of immune checkpoint inhibitor cancer therapy in patients with preexisting type 1 diabetes mellitus.
Robin Hilder, Karen Tsai, Zoe Quandt, Dayna Isaacs, Alexandra Drakaki, Yan Xing, Gino K In, Trevor E Angell, Melissa G Lechner> ;Frontiers in Endocrinology. 2023 Jan 1
1 citations
Prevalence and correlates of skin examination among ethnically diverse young adult survivors of childhood cancer.
Kimberly A Miller, Angela A Li, Katherine Y Wojcik, Julia Stal, Myles G Cockburn, Gino K In, David R Freyer, Ann S Hamilton, Joel E Milam> ;Cancer Medicine. 2023 Apr 1
4 citations
Factors Associated With Hospitalization Among Breast Cancer Patients With COVID-19: A Diverse Multi-Center Los Angeles Cohort Study.
Nikhita Kathuria-Prakash, Lauren Antrim, Nicholas Hornstein, Alexander W Sun, Irene M Kang, Nikita V Baclig, Trevor E Angell, Melissa G Lechner, Noah Wald-Dickler, Gin...> ;Clinical Breast Cancer. 2022 Jun 1
3 citations
Development of a core outcome set for basal cell carcinoma.
Daniel I Schlessinger, Kelly A Reynolds, McKenzie A Dirr, Sarah A Ibrahim, Arianna F Yanes, Jake M Lazaroff, Victoria Godinez-Puig, Brian R Chen, Anastasia O Kurta, Ji...> ;Journal of the American Academy of Dermatology. 2022 Sep 1
4 citations
Clinical activity of PD-1 inhibition in the treatment of locally advanced or metastatic basal cell carcinoma.
Gino Kim In, Aparna Nallagangula, Jacob Seung Choi, Lisa Tachiki, Matthew J Blackburn, Stephen Capone, Kathryn B Bollin, Daniel Y Reuben, Keisuke Shirai, Sandy Zhang-N...> ;Journal for Immunotherapy of Cancer. 2022 May 1
Transcriptional Profiling of Malignant Melanoma Reveals Novel and Potentially Targetable Gene Fusions.
Sourat Darabi, Andrew Elliott, David R Braxton, Jia Zeng, Kurt Hodges, Kelsey Poorman, Jeff Swensen, Basavaraja U Shanthappa, James P Hinton, Geoffrey T Gibney, Justin...> ;Cancers. 2022 Mar 15
Social networks of oncology clinicians as a means for increasing survivorship clinic referral.
Sarah E Piombo, Kimberly A Miller, David R Freyer, Joel E Milam, Anamara Ritt-Olson, Gino K In, Thomas W Valente> ;Communications Medicine. 2022 Jan 1
8 citations
Disparities in non-melanoma skin cancer in Hispanic/Latino patients based on Mohs micrographic surgery defect size, a multicenter retrospective study
Laura Y. Blumenthal, Julia Arzeno, Sina Rabi, Margaret Huang, Erick R Castellanos, Patrick Tran, Trevor A. Pickering, Emily J. Dantus, Gino K. In, Teresa Soriano, Jenn...> ;Journal of the American Academy of Dermatology. 2021 Sep 4
9 citations
Characterizing DNA methylation signatures and their potential functional roles in Merkel cell carcinoma.
Hemant Gujar, Arjun Mehta, Hong-Tao Li, Yvonne C. Tsai, Xiangning Qiu, Daniel J. Weisenberger, Miriam Galvonas Jasiulionis, Gino K. In, Gangning Liang> ;Genome Medicine. 2021 Aug 16
9 citations
Acral lentiginous melanoma—Population, treatment, and survival using the NCDB from 2004 to 2015
Shelly X. Bian, Lindsay Hwang, Omar Ragab, Gino K. In, David Peng, Eugene Lin> ;Pigment Cell & Melanoma Research. 2021 Aug 2
Cutaneous Malignancies of the Head and Neck.
Gino K. In, Jacob Stephen Thomas, Ann W Silk> ;Hematology/oncology Clinics of North America. 2021 Jul 16
2 citations
A Case Series of Multiple Primary Malignancies Among Patients With Advanced Melanoma
Matthew Isaiah Ebia, Stephen Capone, Charité Ricker, Jacob Stephen Thomas, Varsha Tulpule, Irene Kang, Anishka D'souza, David R. Freyer, Kimberly A. Miller, Gino K. In> ;Cureus. 2021 Jun 6
Examining low rates of dermatology visits in solid organ transplant recipients.
Braulio Fernandez, Melanie Miller, Tiffany J. Sierro, Ema Shah, Shannon Wong-Michalak, Renee Haughton, Jack Rodman, Michael E. Fong, Sivagini Ganesh, Hyosun Han, Gino ...> ;Journal of the American Academy of Dermatology. 2021 May 28
16 citations
The time to offer treatments for COVID-19.
Binh Ngo, Paul E. Marik, Pierre Kory, Leland Shapiro, Raphael Thomadsen, Jose Iglesias, Stephen Ditmore, Marc Rendell, Joseph Varon, Michael P. Dubé, Neha Nanda, Gino ...> ;Expert Opinion on Investigational Drugs. 2021 Jan 1
6 citations
Targeting the IL-2 inducible kinase in melanoma; a phase 2 study of ibrutinib in systemic treatment-refractory distant metastatic cutaneous melanoma: preclinical ratio...
Stergios J. Moschos, Zeynep Eroglu, Nikhil I. Khushalani, Kari Kendra, George Ansstas, Gino K. In, Peng Wang, Glenn Liu, Frances A. Collichio, Paul B. Googe, Craig C. ...> ;Melanoma Research. 2021 Apr 1
48 citations
The Importance of Understanding the Stages of COVID-19 in Treatment and Trials.
Daniel O. Griffin, Denise Brennan-Rieder, Binh Ngo, Pierre Kory, Marco Confalonieri, Leland Shapiro, Jose Iglesias, Michael P. Dubé, Neha Nanda, Gino K. In, Daniel G. ...> ;AIDS Reviews. 2021 Feb 8
1 citations
18F-FDG PET/CT Monitoring of Response to Programmed Death Protein 1 Blockade in Metastatic Basal Cell Carcinoma.
Hossein Jadvar, Gino K. In> ;Clinical Nuclear Medicine. 2021 Jan 28
10 citations
COVID-19 Outcomes of Patients With Differentiated Thyroid Cancer: A Multicenter Los Angeles Cohort Study.
Nikhita Kathuria-Prakash, Tina Mosaferi, Mindy Xie, Lauren Antrim, Trevor E. Angell, Gino K. In, Maureen A. Su, Melissa G. Lechner> ;Endocrine Practice. 2021 Jan 4
7 citations
Impact of COVID-19 infection among cancer patients treated at the Los Angeles County Medical Center.
Lauren Antrim, Stephen Capone, Stephen Dong, David Chung, Sonia Lin, Noah Wald-Dickler, Gino K. In> ;Cancer Treatment and Research Communications. 2021 Jan 1
Join now to see all